Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study
Open Access
- 11 November 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Intensive Care Medicine
- Vol. 43 (1), 59-68
- https://doi.org/10.1007/s00134-016-4613-z
Abstract
Purpose The intestinal microbiota has emerged as a virtual organ with essential functions in human physiology. Antibiotic-induced disruption of the microbiota in critically ill patients may have a negative influence on key energy resources and immunity. We set out to characterize the fecal microbiota composition in critically ill patients both with and without sepsis and to explore the use of microbiota-derived markers for clinical outcome measurements in this setting. Methods In this prospective observational cohort study we analyzed the fecal microbiota of 34 patients admitted to the intensive care unit. Fifteen healthy subjects served as controls. The fecal microbiota was phylogenetically characterized by 16S rRNA gene sequencing, and associations with clinical outcome parameters were evaluated. Results A marked shift in fecal bacterial composition was seen in all septic and non-septic critically ill patients compared with controls, with extreme interindividual differences. In 13 of the 34 patients, a single bacterial genus made up >50% of the gut microbiota; in 4 patients this was even >75%. A significant decrease in bacterial diversity was observed in half of the patients. No associations were found between microbiota diversity, Firmicutes/Bacteroidetes ratio, or Gram-positive/Gram-negative ratio and outcome measurements such as complications and survival. Conclusions We observed highly heterogeneous patterns of intestinal microbiota in both septic and non-septic critically ill patients. Nevertheless, some general patterns were observed, including disappearance of bacterial genera with important functions in host metabolism. More detailed knowledge of the short- and long-term health consequences of these major shifts in intestinal bacterial communities is needed.Keywords
Funding Information
- ZonMw (836011024, 016156475)
- Center for Translational Molecular Medicine (04I-201)
This publication has 40 references indexed in Scilit:
- Role of the microbiome, probiotics, and ‘dysbiosis therapy’ in critical illnessCurrent Opinion in Critical Care, 2016
- Sepsis: pathophysiology and clinical managementBMJ, 2016
- Similar Depletion of ProtectiveFaecalibacterium prausnitziiin Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis SuppurativaJournal of Crohn's and Colitis, 2016
- Fecal Microbiota TransplantJournal of Intensive Care Medicine, 2015
- Effects of bowel cleansing on the intestinal microbiotaGut, 2014
- Membership and Behavior of Ultra-Low-Diversity Pathogen Communities Present in the Gut of Humans during Prolonged Critical IllnessmBio, 2014
- Rectal Swabs for Analysis of the Intestinal MicrobiotaPLOS ONE, 2014
- Acute Respiratory Distress SyndromeJama-Journal Of The American Medical Association, 2012
- Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humansJCI Insight, 2010
- Impact of digestive and oropharyngeal decontamination on the intestinal microbiota in ICU patientsIntensive Care Medicine, 2010